I am not certain as to the similarities other then they both use a trans-dermal gel. Male testosterone medication is usually at a higher dose then what is required for women. Therefore Libigel is required for a safe method to restore post menopausal women testosterone levels. Even if the Female Viagra may not be in play as anticipated.
There is still an unmet need for female testosterone restoration where Libigel is the only company in a position to address this need because of the extensive safety trials. The success of the safety trials to date estimate a 90% chance of approval based on safety.
Biosante may be able to save the Female Viagra image with subset data analysis or another more restricted trial. Their meeting with the FDA will no doubt dictate what avenue they will pursue.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.